Please sign in to follow a disease.
No more needles? new scans could replace kidney biopsies
NCT ID NCT06472947
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests two new imaging techniques—ultrasound localization microscopy and multispectral optoacoustic tomography—to check the health of kidney transplants without invasive procedures. Ten adult kidney transplant patients who already need a biopsy will also get these scans. The goal is to see if the scans can provide the same information as a biopsy, potentially reducing the need for needles in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to monitor kidney transplants, reducing the need for painful biopsies.
- What could go wrong
- This is a very small early study with only 10 participants, so results may not apply to everyone. The imaging techniques are still experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
10 patients with kidney transplant and indication for kidney biopsy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * kidney transplant * indication for biopsy set in clinical routine * minimum 18 years of age * written consent Exclusion Criteria: * allergy against contrast agents/ SonoVue * tatoos in examined areas * contraindication against SonoVue * pregnant women * breast feeding women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney biopsy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Pediatrics and Adolescent Medicine
RECRUITINGErlangen, Bavaria, 91054, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New fluid aims to keep donated kidneys healthier
- Can a phone app and a coach keep a new kidney healthier?
- A new tool aims to predict and prevent living kidney donor Drop-Out
- Can digital tools and training help more kidney patients get transplants?
- Can a new preservation fluid keep donor kidneys healthier for transplant?
- Oxygen bath for donor kidneys: a new hope for transplant success?